Free Trial

Edgestream Partners L.P. Boosts Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Omega Healthcare Investors logo with Finance background
Remove Ads

Edgestream Partners L.P. grew its stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 398.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 169,000 shares of the real estate investment trust's stock after purchasing an additional 135,062 shares during the period. Edgestream Partners L.P. owned approximately 0.06% of Omega Healthcare Investors worth $6,397,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of OHI. Geode Capital Management LLC increased its position in Omega Healthcare Investors by 3.1% during the third quarter. Geode Capital Management LLC now owns 6,426,129 shares of the real estate investment trust's stock valued at $261,589,000 after acquiring an additional 192,465 shares during the last quarter. State Street Corp boosted its position in Omega Healthcare Investors by 0.9% during the 3rd quarter. State Street Corp now owns 12,339,753 shares of the real estate investment trust's stock valued at $502,228,000 after acquiring an additional 114,085 shares in the last quarter. Assetmark Inc. grew its stake in Omega Healthcare Investors by 2.9% in the fourth quarter. Assetmark Inc. now owns 1,225,923 shares of the real estate investment trust's stock valued at $46,401,000 after purchasing an additional 34,463 shares during the last quarter. Tallon Kerry Patrick purchased a new stake in Omega Healthcare Investors during the fourth quarter valued at approximately $1,250,000. Finally, BNP Paribas Financial Markets grew its stake in Omega Healthcare Investors by 120.8% during the 3rd quarter. BNP Paribas Financial Markets now owns 226,338 shares of the real estate investment trust's stock worth $9,212,000 after buying an additional 123,836 shares during the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Remove Ads

Omega Healthcare Investors Stock Performance

OHI stock traded down $0.93 during midday trading on Tuesday, hitting $36.68. 2,350,338 shares of the stock traded hands, compared to its average volume of 1,660,947. Omega Healthcare Investors, Inc. has a 1-year low of $29.66 and a 1-year high of $44.42. The company has a debt-to-equity ratio of 1.02, a current ratio of 7.07 and a quick ratio of 7.07. The stock's fifty day simple moving average is $37.11 and its 200-day simple moving average is $39.00. The firm has a market cap of $10.34 billion, a P/E ratio of 23.67, a PEG ratio of 1.09 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. On average, analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were given a $0.67 dividend. The ex-dividend date was Monday, February 10th. This represents a $2.68 annualized dividend and a dividend yield of 7.31%. Omega Healthcare Investors's dividend payout ratio (DPR) is presently 172.90%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on OHI shares. Mizuho raised their price target on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a "neutral" rating in a report on Thursday, December 5th. BMO Capital Markets upgraded Omega Healthcare Investors from a "market perform" rating to an "outperform" rating and set a $45.00 price objective for the company in a research note on Monday, December 9th. JMP Securities reiterated a "market perform" rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Royal Bank of Canada increased their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a "sector perform" rating in a report on Monday, November 11th. Finally, Wells Fargo & Company reduced their target price on shares of Omega Healthcare Investors from $43.00 to $41.00 and set an "overweight" rating for the company in a report on Monday. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, Omega Healthcare Investors presently has an average rating of "Moderate Buy" and a consensus target price of $41.44.

Read Our Latest Research Report on Omega Healthcare Investors

Omega Healthcare Investors Profile

(Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Featured Stories

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Should You Invest $1,000 in Omega Healthcare Investors Right Now?

Before you consider Omega Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.

While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads